Topotecan for Relapsed Small-cell Lung Cancer: Systematic Review and Meta-Analysis of 1347 Patients

Topotecan is the most reliable chemotherapy regimen for relapsed small-cell lung carcinoma (SCLC). The efficacy and adverse effects of topotecan as reported by previous studies varied greatly. The inclusion criterion was a prospective study that was able to provide data for 6-month over-all survival...

Descripción completa

Detalles Bibliográficos
Autores principales: Horita, Nobuyuki, Yamamoto, Masaki, Sato, Takashi, Tsukahara, Toshinori, Nagakura, Hideyuki, Tashiro, Ken, Shibata, Yuji, Watanabe, Hiroki, Nagai, Kenjiro, Inoue, Miyo, Nakashima, Kentaro, Ushio, Ryota, Shinkai, Masaharu, Kudo, Makoto, Kaneko, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614251/
https://www.ncbi.nlm.nih.gov/pubmed/26486755
http://dx.doi.org/10.1038/srep15437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614251/
https://www.ncbi.nlm.nih.gov/pubmed/26486755
http://dx.doi.org/10.1038/srep15437

Ejemplares similares